Efficacy of Olanzapine in Improving Task Engagement in Schizophrenia.
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 26 Dec 2013
At a glance
- Drugs Olanzapine (Primary) ; Antipsychotics
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 26 Dec 2013 Status changed from completed to withdrawn prior to recruitment as per ClinicalTrials.gov record
- 01 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Mar 2012 Additional lead trial centre identified as reported by ClinicalTrials.gov.